02 October 2023

New partner in Luxembourg: GSK Stockmann brings Anna Gassner on board

Anna Gassner will be joining GSK Stockmann’s team in Luxembourg as of 1 October 2023. The addition of a new partner is part of the firm’s strategy to further expand its advisory services in the areas of corporate M&A and private equity.

Anna Gassner (43) will be joining GSK Stockmann’s Luxembourg team as an equity partner on 1 October 2023. She specialises in corporate M&A and private equity and will be joining the firm from Luther’s Luxembourg office, where she has worked since 2018 and is currently a partner. She was admitted to practise law in France in 2009 and worked as a lawyer in Paris for several years before being admitted to practise law in Luxembourg. Anna Gassner will be bringing not only valuable expertise to GSK’s Luxembourg office, but will also be focusing in particular on advising international clients.

Since the opening of the firm’s Luxembourg office in 2016 and London office in 2022, GSK Stockmann has placed a strong focus on complex private equity, venture capital and real estate transactions structured via Luxembourg and London. The M&A expertise of the new equity partner will help to boost the range of advisory services offered at the international level.

“We are very pleased to have Anna Gassner join us as an expert in our corporate M&A and private equity practice. This is how we are setting the course for the firm’s continued successful international outlook”, said Managing Partner Oliver Glück about the new partner. “Our decision complements the strategic expansion of GSK Stockmann, which remains on a successful path.”


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 28.02.2024

    GSK Update: GSK Stockmann contributed to the publication of the International Comparative Legal Guide to Mergers and Acquisitions

    Read more
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
© GSK Stockmann 2024